Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.

Cardiology Consensus Heart Failure / diagnosis Humans Patient Readmission Risk Factors
Diabetes mellitus Epidemiology Heart failure Population attributable risks Prevention  Arterial hypertension

Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
19 02 2022
Historique:
received: 01 07 2021
revised: 15 08 2021
accepted: 18 08 2021
pubmed: 28 1 2022
medline: 6 4 2022
entrez: 27 1 2022
Statut: ppublish

Résumé

The heart failure epidemic is growing and its prevention, in order to reduce associated hospital readmission rates and its clinical and economic burden, is a key issue in modern cardiovascular medicine. The present consensus document aims to provide practical evidence-based information to support the implementation of effective preventive measures. After reviewing the most common risk factors, an overview of the population attributable risks in different continents is presented, to identify potentially effective opportunities for prevention and to inform preventive strategies. Finally, potential interventions that have been proposed and have been shown to be effective in preventing HF are listed.

Identifiants

DOI: 10.1093/eurjpc/zwab147 PMID: 35083485
pubmed: 35083485
pii: 6515714
doi: 10.1093/eurjpc/zwab147
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

275-300

Commentaires et corrections

Type : ErratumIn

Informations de copyright

The article has been co-published with permission in the European Journal of Preventive Cardiology and European Journal of Heart Failure. All rights reserved. © The Author(s) 2022. The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Either citation can be used when citing this article.

Auteurs

Massimo F Piepoli (MF)

Cardiac Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy.
Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
ORCID: 0000-0003-1124-234X

Marianna Adamo (M)

Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy.
ORCID: 0000-0002-3855-1815

Andrea Barison (A)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
ORCID: 0000-0001-9042-340X

Reinaldo B Bestetti (RB)

Universidade de Ribeirão Preto, Ribeirão Preto, Brazil.

Jan Biegus (J)

Department of Heart Diseases, Medical University, Wroclaw, Poland.
ORCID: 0000-0001-9977-7722

Michael Böhm (M)

Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Homburg/Saar, Germany.

Javed Butler (J)

Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.

Jonathan Carapetis (J)

Telethon Kids Institute, University of Western Australia and Perth Children's Hospital, Perth, Australia.

Claudio Ceconi (C)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Ovidiu Chioncel (O)

University of Medicine Carol Davila, Bucharest, Romania.
Emergency Institute for Cardiovascular Diseases 'C.C. Iliescu', Bucharest, Romania.

Andrew Coats (A)

University of Warwick, Coventry, UK.

Maria G Crespo-Leiro (MG)

Complexo Hospitalario Universitario A Coruña (CHUAC): CIBERCV, Universidade da Coruña (UDC), Instituto Ciencias Biomedicas A Coruña (INIBIC), A Coruña, Spain.

Giovanni de Simone (G)

Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
ORCID: 0000-0001-8567-9881

Heinz Drexel (H)

Department of Medicine, Landeskrankenhaus Bregenz, Bregenz, Austria.
VIVIT, Landeskrankenhaus Feldkirch, Feldkirch, Austria.
ORCID: 0000-0001-8191-9761

Michele Emdin (M)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Dimitros Farmakis (D)

University of Cyprus Medical School, Nicosia, Cyprus.

Martin Halle (M)

Sport and Health Sciences, Policlinic for Preventive and Rehabilitative Sports Medicine, TUM School of Medicine, Munich, Germany.
ORCID: 0000-0003-3065-530X

Stephane Heymans (S)

Department of Cardiology, Maastricht University, CARIM School for Cardiovascular Diseases, Maastricht, Netherlands.
Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Belgium.

Tiny Jaarsma (T)

Department of Health, Medicine and Caring Sciences, Linkoping University, Linköping, Sweden.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
ORCID: 0000-0002-4197-4026

Ewa Jankowska (E)

Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.

Mitja Lainscak (M)

Division of Cardiology, General Hospital Murska Sobota and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Faculty of Natural Sciences and Mathematics, University of Maribor, Maribor, Slovenia.

Carolyn S P Lam (CSP)

National Heart Centre Singapore, Duke-National University of Singapore, Singapore, Singapore.
ORCID: 0000-0003-1903-0018

Maja-Lisa Løchen (ML)

Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
ORCID: 0000-0002-8532-6573

Yuri Lopatin (Y)

Volgograd State Medical University, Regional Cardiology Centre, Volgograd, Russian Federation.

Aldo Maggioni (A)

ANMCO Research Center, Florence, Italy.

Benedetta Matrone (B)

Cardiac Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy.

Marco Metra (M)

Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy.

Katharine Noonan (K)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Ileana Pina (I)

Detroit Medical Center, Detroit, MI, USA.

Eva Prescott (E)

Bispebjerg Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.
ORCID: 0000-0002-4134-0349

Giuseppe Rosano (G)

IRCCS San Raffaele, Roma, Italy.
ORCID: 0000-0002-6868-4248

Petar M Seferovic (PM)

Belgrade University Faculty of Medicine, Serbian Academy of Science and Arts, Belgrade, Serbia.

Karen Sliwa (K)

University of Cape Town, Cape Town, South Africa.

Simon Stewart (S)

Torrens University Australia, Adelaide, South Australia, Australia.

Alicia Uijl (A)

Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Belgium.
Division of Heart & Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Ilonca Vaartjes (I)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Roel Vermeulen (R)

Division of Heart & Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
ORCID: 0000-0003-4082-8163

W M Verschuren (WM)

National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.

Maurizio Volterrani (M)

IRCCS San Raffaele, Roma, Italy.

Stephan Von Haehling (S)

Department of Cardiology and Pneumology, Heart Center, University of Göttingen Medical Center, Göttingen, Germany.
German Center for Cardiovascular Research (DZHK), partner site Göttingen, Germany.

Arno Hoes (A)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Professions de santé › Médecine › Médecine interne › Cardiologie › Preventing heart failure: a position paper of...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Preventing heart failure: a position paper of...
questionsmedicales.fr › Maladies cardiovasculaires › Cardiopathies › Défaillance cardiaque › Preventing heart failure: a position paper of...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Preventing heart failure: a position paper of...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Soins aux patients › Hospitalisation › Réadmission du patient › Preventing heart failure: a position paper of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Preventing heart failure: a position paper of...